Insulet Agrees To Pay $19.5M To End Investor Suit
Insulet Corp. has agreed to a $19.5 million settlement of a proposed class action alleging the medical device maker misled investors about the success of a new insulin infusion pump system...To view the full article, register now.
Already a subscriber? Click here to view full article